Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Advanced NSCLC × Oxaliplatin × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 27 Stomach Neoplasms 23 Pancreatic Neoplasms 15 Colonic Neoplasms 15 Rectal Neoplasms 11 Esophageal Neoplasms 9 Adenocarcinoma Of Esophagus 8 Lymphoma, Large B-Cell, Diffuse 7 Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Adenocarcinoma 6 Cholangiocarcinoma 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Gallbladder Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Hepatoblastoma 2 Gastrointestinal Neoplasms 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Unresectable Colorectal Cancer 1 Triple Negative Breast Neoplasms 1 Spinocerebellar Degenerations 1 Solid Cancer 1 Skin Neoplasms 1

Interventions

Oxaliplatin 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04043195 2025-05-28

NSCLC

University of California, San Diego

Phase 1/2 Active not recruiting

Advanced NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡